8th Mar 2022 7:00 am |
RNS |
Contract worth circa £800k |
14th Feb 2022 7:00 am |
RNS |
Launch of IXIQ.Ai Deep learning AI-based platform |
8th Feb 2022 12:30 pm |
RNS |
Holding(s) in Company |
8th Feb 2022 7:00 am |
RNS |
Contract award worth circa £1.0m |
31st Jan 2022 7:00 am |
RNS |
Appointment of Senior Therapeutic Advisor |
26th Jan 2022 7:00 am |
RNS |
Dementia collaboration |
21st Jan 2022 7:00 am |
RNS |
Non-Executive Director Appointment |
20th Jan 2022 10:50 am |
RNS |
Result of AGM |
20th Jan 2022 7:00 am |
RNS |
Huntington’s disease contract update |
10th Jan 2022 7:00 am |
RNS |
Grant of share options |
7th Dec 2021 7:00 am |
RNS |
Financial Results for the year ended 30 Sept 2021 |
22nd Nov 2021 7:00 am |
RNS |
Notice of Results |
1st Nov 2021 6:08 pm |
RNS |
Holding(s) in Company |
1st Nov 2021 7:00 am |
RNS |
New contract worth >£1.0m |
20th Oct 2021 4:27 pm |
RNS |
Contract update |
18th Oct 2021 7:00 am |
RNS |
Trading Update for year ended 30 September 2021 |
22nd Sep 2021 7:00 am |
RNS |
New contract worth >$750k |
20th Sep 2021 7:00 am |
RNS |
Phase II HD contract with new client worth >$500K |
8th Sep 2021 7:00 am |
RNS |
Phase I MSA contract award worth >$500k |
6th Aug 2021 7:00 am |
RNS |
Trading Update |
23rd Jun 2021 3:32 pm |
RNS |
Issue of Equity |
21st Jun 2021 2:31 pm |
RNS |
Holding(s) in Company |
15th Jun 2021 7:00 am |
RNS |
Further investment in Ixico plc |
11th Jun 2021 11:35 am |
RNS |
Holding(s) in Company |
25th May 2021 7:00 am |
RNS |
Half yearly report to 31 March 2021 |
20th May 2021 7:00 am |
RNS |
Phase II Alzheimer’s disease contract award |
19th May 2021 7:00 am |
RNS |
Contract win for new neuroinflammatory disorder |
11th May 2021 7:00 am |
RNS |
Notice of results |
28th Apr 2021 7:00 am |
RNS |
Contract win for new stroke study |
26th Apr 2021 7:00 am |
RNS |
Trading update |
19th Apr 2021 8:21 am |
RNS |
Holding(s) in Company |
12th Apr 2021 4:00 pm |
RNS |
Holding(s) in Company |
12th Apr 2021 7:00 am |
RNS |
Investment in Ixico plc |
1st Apr 2021 7:00 am |
RNS |
Holding(s) in Company |
25th Mar 2021 9:14 am |
RNS |
PDMR Transaction |
24th Mar 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
24th Mar 2021 9:00 am |
RNS |
Price Monitoring Extension |
23rd Mar 2021 4:40 pm |
RNS |
Second Price Monitoring Extn |
23rd Mar 2021 4:35 pm |
RNS |
Price Monitoring Extension |
23rd Mar 2021 3:05 pm |
RNS |
Huntington’s disease Phase III contract updates |